High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
Impact in
- Oncology 397
- Immunology 382
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm.3773 →Countries where authors are citing High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
This map shows the geographic impact of High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma more than expected).
Fields of papers citing High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
This network shows the impact of High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
About High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
This paper, published in 2014, received 528 indexed citations . Written by Carsten Linnemann, Marit M. van Buuren, Laura Bies, Els M.E. Verdegaal, Remko Schotte, Jorg J. A. Calis, Sam Behjati, Arno Velds, Henk Hilkmann and Dris El Atmioui covering the research area of Immunology and Oncology. It is primarily cited by scholars working on Oncology (397 citations), Immunology (382 citations), Molecular Biology (134 citations), Radiology, Nuclear Medicine and Imaging (42 citations) and Cancer Research (31 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm.3773.